(Q38503576)

3 September 2017

1 reference

title

The role of machine learning in neuroimaging for drug discovery and development (English)

1 reference

3 September 2017

0 references

0 references

1 reference

Orla M Doyle

1

0 references

author name string

Mitul A Mehta

series ordinal

2

1 reference

3 September 2017

Michael J Brammer

series ordinal

3

1 reference

3 September 2017

publication date

28 May 2015

1 reference

3 September 2017

number of pages

11

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

3 September 2017

volume

232

1 reference

3 September 2017

issue

21-22

1 reference

3 September 2017

page(s)

4179-4189

1 reference

A role for fMRI in optimizing CNS drug development

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Use of functional imaging across clinical phases in CNS drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Validation of cerebral blood perfusion imaging as a modality for quantitative pharmacological MRI in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Complex brain networks: graph theoretical analysis of structural and functional systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Additive effects of a cholinesterase inhibitor and a histamine inverse agonist on scopolamine deficits in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Prognostic and diagnostic potential of the structural neuroanatomy of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Automatic classification of patients with Alzheimer's disease from structural MRI: a comparison of ten methods using the ADNI database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Methylphenidate has differential effects on blood oxygenation level-dependent signal related to cognitive subprocesses of reversal learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Oxytocin, vasopressin, and the neurogenetics of sociality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Multivariate decoding of brain images using ordinal regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Quantifying the attenuation of the ketamine pharmacological magnetic resonance imaging response in humans: a validation using antipsychotic and glutamatergic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Bridging paradigms: hybrid mechanistic-discriminative predictive models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Predicting progression of Alzheimer's disease using ordinal regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Learning to identify CNS drug action and efficacy using multistudy fMRI data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Predicting sample size required for classification performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Prognostic prediction of therapeutic response in depression using high-field MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Sample size and statistical power considerations in high-dimensionality data settings: a comparative study of classification algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Predicting treatment response to cognitive behavioral therapy in panic disorder with agoraphobia by integrating local neural information.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

On the interpretation of weight vectors of linear models in multivariate neuroimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Human pharmacological MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Next-generation treatments for mental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

The NIMH Research Domain Criteria (RDoC) Project: precision medicine for psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

The identification and validation of distinct depressive syndromes in a population-based sample of female twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

A pilot study to determine whether machine learning methodologies using pre-treatment electroencephalography can predict the symptomatic response to clozapine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Everything you never wanted to know about circular analysis, but were afraid to ask

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

The scopolamine model as a pharmacodynamic marker in early drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

GPU accelerated support vector machines for mining high-throughput screening data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: a multi-class pattern recognition approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Role of neuroimaging in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Pharmacological application of fMRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Machine learning and data mining: strategies for hypothesis generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

A Spatiotemporal Profile of In Vivo Cerebral Blood Flow Changes Following Intranasal Oxytocin in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Methylphenidate effects on prefrontal functioning during attentional-capture and response inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

A procedural framework for good imaging practice in pharmacological fMRI studies applied to drug development #1: processes and requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

A procedural framework for good imaging practice in pharmacological fMRI studies applied to drug development #2: protocol optimization and best practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Network modelling methods for FMRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Latent class analysis of lifetime depressive symptoms in the national comorbidity survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Potentials and challenges for arterial spin labeling in pharmacological magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

What is the value of human FMRI in CNS drug development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

The role of imaging in proof of concept for CNS drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

A Tutorial on Support Vector Machines for Pattern Recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-3968-0

Comparative behavioral and neurochemical activities of cholinergic antagonists in rats

21 January 2018

1 reference

12 December 2020

Lost in translation: animal models and clinical trials in cancer treatment

1 reference

12 December 2020

Ketamine induces a robust whole-brain connectivity pattern that can be differentially modulated by drugs of different mechanism and clinical profile

1 reference

12 December 2020

A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease

1 reference

12 December 2020

10.1007/S00213-015-3968-0

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

1048181506

0 references

Fatcat ID

release_uzebhwjktbh6lkwlivdepxntme

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uzebhwjktbh6lkwlivdepxntme

24 November 2022

mapped directly with Wikidata item

1 reference